Virtual Reality on Balance of Parkinson's Disease
Effects of Immersive Virtual Reality on Balance of Parkinson's Disease
Instituto de Investigación Sanitaria Aragón
50 participants
Feb 5, 2025
INTERVENTIONAL
Conditions
Summary
This study, titled: Effectiveness of immersive virtual reality on balance in people with Parkinson's disease. Is a randomized clinical trial conducted at Zaragoza Parkinson's Association in Spain. It aims to evaluate the effectiveness of a immersive virtual reality program in enhancing balance for patients with Parkinson.s disease (PD). PD is a neurodegenerative disease that has a major impact on patients' balance and gait, affecting their quality of life. Physical rehabilitation is crucial for maintaining and improving balance, and immersive virtual reality promises to be an alternative for improving outcomes in patients with PD.
Eligibility
Inclusion Criteria5
- Diagnosis of PD confirmed by a neurologist
- Age between 55 and 90 years
- Hoehn \& Yahr Scale score of 1 to 4
- Cognitive level of 24 or higher on the Mini Mental Examination Test
- Ability to stand upright without assistance
Exclusion Criteria4
- Visual or auditory impairments that could interfere with the perception of information or trigger dizziness or epilepsy
- Musculoskeletal conditions that hinder or prevent the execution of exercises or the ability to maintain a standing position for at least 20 minutes
- Psychiatric disorders such as moderate or severe depression diagnosed in the last year and impulse control disorders diagnosed in the last year
- Score of 20 points on the Simulator Sickness Questionnaire (SSQ scale), indicating the presence of severe adverse symptoms
Interventions
The participants in the intervention group will receive a Immersive Virtual Reality Rehabilitation Program to improve static and dynamic balance and quality of life
The participants in the control group will receive a Standard Physical Therapy Rehabilitation Program to improve static and dynamic balance and quality of life
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07274514